Dr. David A. Godin, MD

Dr. Godin practices at ENT and Allergy Associates in New York, New York.

Dr. Godin's NPI, 1053350686, was assigned on June 6, 2006. Dr. Godin graduated from SUNY Upstate Medical University in 1995. Dr. Godin holds New York license 217244.

Dr. Godin's primary practice is ENT and Allergy Associates, at 261 5th Ave, New York, NY 10016 in New York County. The practice phone is (914) 333-5800.

Dr. Godin's primary practice is ENT and Allergy Associates in New York, New York. Dr. Godin is also affiliated with Tisch Hospital. The medical group on file is ENT and Allergy Associates. Dmand AI also links Dr. Godin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Godin practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Godin's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Godin is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Godin's licenses on file in 3 states: New York, New Jersey and Louisiana.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Godin treats.

CMS data shows 843 Medicare services from Dr. Godin across 9 procedure codes in 2024, for 363 Medicare patients. Medicare paid $79,197 for them. Every service was in an office.

CMS counts 363 Medicare patients who saw Dr. Godin in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 7% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Godin's median patient age at 40, with 49% women.

In 2024, Dr. Godin wrote 215 Medicare Part D claims for 123 patients. 95% of them were for generic drugs. CMS names the drug for 157 of them, across 6 drugs with 11 or more claims each, at $4,260 in total drug cost. In 2023, CMS named 113 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Godin for performance year 2024, reported as part of a group. Dr. Godin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 30 papers to Dr. Godin in 2006. The most frequent topics are Antioxidants, Glutathione and Superoxide Dismutase. Dr. Godin has published most often in Can J Cardiol. Dr. Godin's most frequent co-authors are Peter Charles Belafsky, MD, PhD, Mehrdad Nadji and Nazir Ahmad Rahim, MD.

CMS Open Payments shows 309 general payments to Dr. Godin from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Sanofi and Genzyme US Companies paid the most, $3,962.

Dmand AI lists 7 awards for Dr. Godin, most recently New York Magazine: Top Doctors in 2014.

Dr. Godin graduated from SUNY Upstate Medical University in 1995. Dr. Godin is a member of NHS and ACS.

Dr. Godin is in network with 14 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.